243 related articles for article (PubMed ID: 1737937)
1. Analysis of the AP-1 sites in the IL-2 promoter.
Jain J; Valge-Archer VE; Rao A
J Immunol; 1992 Feb; 148(4):1240-50. PubMed ID: 1737937
[TBL] [Abstract][Full Text] [Related]
2. Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1.
Hughes CC; Pober JS
J Immunol; 1993 Apr; 150(8 Pt 1):3148-60. PubMed ID: 8468462
[TBL] [Abstract][Full Text] [Related]
3. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
4. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
McGuire KL; Iacobelli M
J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
[TBL] [Abstract][Full Text] [Related]
6. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
Beiqing L; Chen M; Whisler RL
J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
[TBL] [Abstract][Full Text] [Related]
7. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription.
Petrak D; Memon SA; Birrer MJ; Ashwell JD; Zacharchuk CM
J Immunol; 1994 Sep; 153(5):2046-51. PubMed ID: 8051409
[TBL] [Abstract][Full Text] [Related]
8. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
Iwai K; Mori N; Oie M; Yamamoto N; Fujii M
Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887
[TBL] [Abstract][Full Text] [Related]
9. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells.
Mondino A; Whaley CD; DeSilva DR; Li W; Jenkins MK; Mueller DL
J Immunol; 1996 Sep; 157(5):2048-57. PubMed ID: 8757326
[TBL] [Abstract][Full Text] [Related]
10. Promoter-specific trans-activation and inhibition mediated by JunB.
Hsu JC; Cressman DE; Taub R
Cancer Res; 1993 Aug; 53(16):3789-94. PubMed ID: 8339292
[TBL] [Abstract][Full Text] [Related]
11. Identification of a 10-base pair protein binding site in the promoter of the hamster H3.2 gene required for the S phase dependent increase in transcription and its interaction with a Jun-like nuclear factor.
Naeve GS; Sharma A; Lee AS
Cell Growth Differ; 1992 Dec; 3(12):919-28. PubMed ID: 1472472
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
13. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
14. A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes.
Wang J; Shannon MF; Young IG
Int Immunol; 2006 Feb; 18(2):313-23. PubMed ID: 16373364
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
Parra E; McGuire K; Hedlund G; Dohlsten M
J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
[TBL] [Abstract][Full Text] [Related]
16. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
[TBL] [Abstract][Full Text] [Related]
17. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
[TBL] [Abstract][Full Text] [Related]
18. Activation of the CD2 pathway in lamina propria T cells up-regulates functionally active AP-1 binding to the IL-2 promoter, resulting in messenger RNA transcription and IL-2 secretion.
Gonsky R; Deem RL; Hughes CC; Targan SR
J Immunol; 1998 May; 160(10):4914-22. PubMed ID: 9590239
[TBL] [Abstract][Full Text] [Related]
19. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
Jenkins F; Cockerill PN; Bohmann D; Shannon MF
J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
[TBL] [Abstract][Full Text] [Related]
20. Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1.
Castellanos MC; Muñoz C; Montoya MC; Lara-Pezzi E; López-Cabrera M; de Landázuri MO
J Immunol; 1997 Dec; 159(11):5463-73. PubMed ID: 9580241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
